The Enterprise Value as of December 2025 (TTM) for GT Biopharma, Inc. (GTBP) is 4.16M

According to GT Biopharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.16M. This represents a change of 85.17% compared to the average of 2.25M of the last 4 quarters.

GT Biopharma, Inc. (GTBP) Historical Enterprise Value (quarterly & annually)

How has GTBP Enterprise Value performed in the past?

The mean historical Enterprise Value of GT Biopharma, Inc. over the last ten years is 779.68M. The current 4.16M Enterprise Value has changed -46.62% with respect to the historical average. Over the past ten years (40 quarters), GTBP's Enterprise Value was at its highest in in the December 2017 quarter at 6.69B. The Enterprise Value was at its lowest in in the June 2024 quarter at -4695080.00.

GT Biopharma, Inc. (GTBP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of GT Biopharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

GT Biopharma, Inc. (GTBP) Average Enterprise Value

How has GTBP Enterprise Value performed in the past?

The current Enterprise Value of GT Biopharma, Inc. (GTBP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

GT Biopharma, Inc. (GTBP) Enterprise Value vs. Peers

How is GTBP’s Enterprise Value compared to its peers?

GT Biopharma, Inc.’s Enterprise Value is greater than Artelo Biosciences, Inc. (2.99M), greater than Protagenic Therapeutics, Inc. (3.67M), greater than Carisma Therapeutics, Inc. (1.75M), greater than Salarius Pharmaceuticals, Inc. (293.35K), less than Windtree Therapeutics, Inc. (5.19M), greater than Psyence Biomedical Ltd. (-4844216.00), greater than Silexion Therapeutics Ltd. (2.01M), greater than Lipella Pharmaceuticals Inc. (-1590260161.00), greater than Dermata Therapeutics, Inc. (-2946603.00), greater than Revelation Biosciences, Inc. (-6784353.00),

Build a custom stock screener for GT Biopharma, Inc. (GTBP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GT Biopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

GT Biopharma, Inc. (GTBP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like GT Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.